USP <1207>
USP <1207> guides package integrity evaluation for sterile products, including leak-test method selection, validation concepts, leakage-risk contex...
AlignedStandards
Package Integrity CCIUSP <1207>ISO 11607
Standards cluster for sterile package integrity, container closure integrity, and sterile barrier validation evidence.
Use it when leak detection, seal quality, sterile barrier performance, conditioning history, and packaging-process documentation need one defensible study frame.
Standard roster
Individual standards in this cluster
USP <1207>, ISO 11607 / Part 1, and ISO 11607 / Part 2 form the citation set; ARE Labs translates them into CCI method selection, fixture controls, package conditioning records, QA review, and report outputs.
ISO 11607 / Part 1
ISO 11607 / Part 1 defines requirements and test-method context for materials, sterile barrier systems, and packaging systems for terminally steril...
AlignedISO 11607 / Part 2
ISO 11607 / Part 2 frames validation requirements for packaging processes such as forming, sealing, and assembly.
AlignedPurpose & when to use
Package integrity CCI studies evaluate whether sealed packages and container closure systems protect sterile product quality through handling, storage, sterilization, or change control. This Standards cluster helps teams decide how USP <1207>, ISO 11607 / Part 1, and ISO 11607 / Part 2 should frame leak detection, seal quality, sterile barrier evidence, and packaging-process documentation:
- Sterile pharmaceutical teams use USP <1207> when container closure integrity, leak-method selection, and seal quality need one defensible rationale.
- Medical device packaging teams use ISO 11607 / Part 1 when sterile barrier materials, packaging systems, and post-conditioning evidence must be documented.
- Manufacturing or validation teams use ISO 11607 / Part 2 when forming, sealing, or assembly processes need validation records tied to package integrity.
- Change-control programs use USP <1207> and ISO 11607 to compare lots, suppliers, closures, conditioning states, or package configurations.
Use this cluster when the question is not only whether a package leaked, but whether the selected method, sample history, controls, acceptance criteria, and report language support the package-risk decision.
Applicable to
Built around sterile package decisions
The cluster applies when package integrity depends on closure design, sterile barrier materials, sealing process, conditioning state, leak sensitivity, or regulatory documentation expectations.
Standards in this group
What each citation controls
This page is a cluster for package integrity and sterile barrier evidence, not a replacement for official standard text. USP <1207> provides the container closure integrity frame for sterile products, while ISO 11607 / Part 1 and ISO 11607 / Part 2 frame medical-device sterile barrier systems and packaging-process validation. ARE Labs maps each citation to protocol decisions, controls, records, and report boundaries.
USP
AlignedUSP <1207>
Package Integrity Evaluation - Sterile Products
USP <1207> guides package integrity evaluation for sterile products, including leak-test method selection, validation concepts, leakage-risk context, and seal quality. ARE Labs uses it to frame CCI protocols, method sensitivity, controls, deviations, and package integrity report language without reproducing protected chapter text.
USP official preview page verified 2026-05-17; preview cites United States Pharmacopeia (2017), but no exact effective date was confirmed.
ISO
AlignedISO 11607 / Part 1
Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems and packaging systems
ISO 11607 / Part 1 defines requirements and test-method context for materials, sterile barrier systems, and packaging systems for terminally sterilized medical devices. ARE Labs uses it to connect package design, material state, conditioning history, barrier evidence, and integrity results to validation documentation.
ISO official page verified 2026-05-17; edition 2 published 2019-02, confirmed in 2024, with Amendment 1:2023; exact day not stated.
ISO
AlignedISO 11607 / Part 2
Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes
ISO 11607 / Part 2 frames validation requirements for packaging processes such as forming, sealing, and assembly. ARE Labs uses it when CCI or seal quality data must be interpreted beside process settings, process validation evidence, package assembly controls, and documented acceptance criteria.
ISO official page verified 2026-05-17; edition 2 published 2019-02, confirmed in 2024, with Amendment 1:2023; exact day not stated.
Aligned by protocol, not certified by citation
ARE Labs treats this cluster as standards-aligned package integrity support. USP <1207>, ISO 11607 / Part 1, and ISO 11607 / Part 2 are followed by protocol where applicable; formal accreditation is not claimed for these individual citations.
- USP <1207>AlignedCCI guidance translated into method and report controls.
- ISO 11607 / Part 1AlignedSterile barrier requirements mapped to package evidence.
- ISO 11607 / Part 2AlignedPackaging process validation context followed by protocol.
Operational chain
How ARE Labs turns the standards into a study
Package integrity standards become useful only after the package format, closure mechanism, target defect, conditioning state, method sensitivity, and validation decision are fixed. ARE Labs translates USP and ISO expectations into setup, operation, evidence, and report controls.
01
Configuration
Select the integrity method
We map USP <1207> objectives to dye, bubble, decay, microbial barrier, or fit-for-purpose CCI methods based on package risk and sensitivity needs.
Method rationale02
Package state
Lock sample history
ISO 11607 / Part 1 framing makes package material, sterile barrier format, sterilization state, aging condition, and distribution history part of the setup record.
Sample history03
Process link
Connect seals to validation
ISO 11607 / Part 2 context ties CCI findings to forming, sealing, assembly settings, process windows, acceptance criteria, and change-control questions.
Validation linkage04
Controls
Verify the test run
USP <1207> and ISO 11607 studies document fixtures, leak standards or positive controls, negative controls, pressure or vacuum checks, and deviations.
Traceable run log05
Reporting
Make the evidence reviewable
Reports connect USP <1207> and ISO 11607 citation choices to package configuration, replicate results, conditioning records, method limits, deviations, and QA review.
Review-ready reportData quality, QA/QC & documentation
CCI results are defensible only when package identity, sample condition, fixtures, controls, and acceptance criteria remain traceable. ARE Labs ties USP and ISO study framing to receipt records, conditioning history, equipment checks, control outcomes, raw data, deviations, and QA review so package decisions can be audited.
Identify each package state
ISO 11607 / Part 1 studies link lot, material, sterile barrier format, sterilization state, aging condition, and handling history to each result.
Document the leak method
USP <1207> framing records method selection, fixture setup, sensitivity rationale, leak standards or controls, and observed package responses.
Preserve seal-process context
ISO 11607 / Part 2 context keeps forming, sealing, assembly settings, process changes, and validation links visible beside CCI results.
Confirm run validity
USP <1207> and ISO 11607 records include positive controls, negative controls, instrument checks, pressure or vacuum verification, and deviations.
Separate evidence from claims
ISO 17025 review language distinguishes aligned USP and ISO testing from product certification, regulatory approval, or unverified accreditation claims.
Why ARE Labs
ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.
Reviewed byJamie Balarashti - Weston Schaper
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported
Common questions
These questions cover how packaging, quality, validation, and regulatory teams decide whether CCI work belongs under USP <1207>, ISO 11607 / Part 1, ISO 11607 / Part 2, or a fit-for-purpose protocol. The answers focus on method selection, accreditation language, documentation, and report evidence before protocol drafting begins.
Q. Which citation applies?
A. USP <1207> usually frames sterile product CCI and leak-method rationale. ISO 11607 / Part 1 frames sterile barrier materials and packaging systems. ISO 11607 / Part 2 frames forming, sealing, and assembly process validation.
Q. Are these standards accredited?
A. No individual USP <1207> or ISO 11607 accreditation is claimed on this page. ARE Labs performs aligned testing by protocol and separates that from ISO 17025 quality-system language.
Q. Can one study cite both USP and ISO?
A. Yes, when the product and decision justify it. A sterile package study may use USP <1207> for CCI rationale and ISO 11607 for sterile barrier or process-validation context.
Q. What if my package does not fit?
A. ARE Labs can write a fit-for-purpose protocol. The study record documents the selected references, package constraints, method limits, controls, deviations, and interpretation boundaries.
Q. What does the report include?
A. Reports can include package setup, conditioning history, method rationale, control results, leak or seal observations, replicate variability, acceptance criteria, deviations, raw data references, and QA/QC notes.
Related services & devices
Related services & devices
Service
Package Integrity & Sterility
Primary service route for leak methods, microbial barrier evidence, fixtures, controls, and CCI reporting.Read more ->ServiceStability & Accelerated Aging
Pairs with integrity checks when heat, humidity, time, or aging state may alter package barriers.Read more ->ServiceShelf-Life Studies
Adds scheduled pulls when leakage, seal drift, or barrier evidence must be trended over storage.Read more ->DevicesSterile Medical Device Packaging
Pouches, trays, lids, and kits where ISO 11607 context shapes validation evidence.Read more ->ServiceCleaning Validation Testing
Adds residue removal and material compatibility evidence when cleaner exposure may affect package components.Read more ->DevicesMedical Device Surface Treatment
Adjacent route when coatings, adhesives, or treated surfaces affect seal or material decisions.Read more ->Related clusters
Related standards clusters
Package integrity sits beside cleaning compatibility, distribution stress, sterility validation, and stability evidence. These neighboring clusters help teams route from CCI into adjacent validation or package-risk questions.
Standards - Live